Bjorklund v. Novo Nordisk A/S et al
| Jaclyn Bjorklund |
| NOVO NORDISK A/S, NOVO NORDISK NORTH AMERICA OPERATIONS A/S, Novo Nordisk U S Holdings Inc, Novo Nordisk U S Commercial Holdings Inc, NOVO NORDISK INC., NOVO NORDISK RESEARCH CENTER SEATTLE INC., Novo Nordisk Pharmaceutical Industries L P and ELI LILLY & CO |
| 2:2024cv00533 |
| February 5, 2024 |
| US District Court for the Eastern District of Pennsylvania |
| GENE EK PRATTER |
| P.I.: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-Personal Injury |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 14, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 109
ORDER THAT THE MOTIONS FOR PRO HAC VICE ADMISSION ARE GRANTED. SIGNED BY DISTRICT JUDGE GENE E.K. PRATTER ON 3/14/24.3/14/24 ENTERED AND COPIES E-MAILED.(jaa, )
|
| Filing Fee for #106 PRO HAC VICE of Jonathan Sedgh by Jaclyn Bjorklund. (Filing Fee $75, receipt number APAEDC-17287827). (AUTRY, JOSHUA) Modified on 2/26/2024 (tjd). |
| Filing 108 MOTION for Pro Hac Vice for Nicole Lovett ( Filing fee $ 75 receipt number BPAEDC-17281356.) filed by Jaclyn Bjorklund.Motion for Pro Hac Vice.(AUTRY, JOSHUA) |
| Filing 107 MOTION for Pro Hac Vice for Paul Pennock ( Filing fee $ 75 receipt number APAEDC-17281354.) filed by Jaclyn Bjorklund.Motion for Pro Hac Vice.(AUTRY, JOSHUA) |
| Filing 106 MOTION for Pro Hac Vice for Jonathan Sedgh filed by Jaclyn Bjorklund.Motion for Pro Hac Vice.(AUTRY, JOSHUA) |
| Filing 105 NOTICE of Appearance by JOSHUA M. AUTRY on behalf of Jaclyn Bjorklund (AUTRY, JOSHUA) |
| MDL-3094 (Judge Pratter) Member Case. WD-LA 2:23cv1020. Case number in EDPA: 2:24cv533. (nd) |
| Filing 104 Case transferred in from District of Louisiana Western; Case Number 2:23-cv-01020. Original file certified copy of transfer order and docket sheet received. |
|
Filing 103
ORDER FOR MULTI-DISTRICT LITIGATION TRANSFER directing transfer to Eastern District of Pennsylvania, In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL # 3094. Record electronically transmitted to receiving court. Case Terminated. All future pleadings should be filed with the newly assigned court. (crt,Alexander, E) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 102 NOTICE received via email from Clerk of Judicial Panel on Multidistrict Litigation transmitting Conditional Transfer Order in MDL No.3094, IN RE: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation advising case shall be transferred to the Eastern District of Pennsylvania upon request of the record. (crt,Alexander, E) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 101
ELECTRONIC ORDER granting #98 Motion for Extension of Time to Answer re #98 MOTION for Extension of Time to File Answer with consent . Answer of defendant Eli Lilly & Co due 30 days after a decision by the JPML on In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Litigation, MDL No. 3094. Signed by Judge James D Cain, Jr on 1/30/2024. (crt,Higgins, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Motions Transferred regarding #98 MOTION for Extension of Time to File Answer with consent , #99 MOTION for Protective Order . Motions referred to Judge James D Cain, Jr. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| MOTION for Hearing re #99 MOTION for Protective Order by Eli Lilly & Co. Motions referred to Magistrate Judge Thomas P LeBlanc. Motion Ripe Deadline set for 1/29/2024. ADMINISTRATIVE ENTRY to capture Request for Status Conference contained within PDF of #100 Response to Motion.(crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Motions Transferred regarding MOTION for Hearing re #99 MOTION for Protective Order . Motions referred to Judge James D Cain, Jr. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 100 RESPONSE to Motion re #99 MOTION for Protective Order ELI LILLY AND COMPANYS BRIEF AND REQUEST FOR STATUS CONFERENCE REGARDING PROPOSED PROTECTIVE ORDER PROVISIONS TO PROTECT CONFIDENTIAL INFORMATION FROM COMPETITORS filed by Eli Lilly & Co. (aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 99 MOTION for Protective Order by Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Thomas P LeBlanc. Motion Ripe Deadline set for 1/29/2024. (Attachments: #1 Memorandum / Brief, #2 Proposed order, #3 Exhibit A - Francis Protective Order, #4 Exhibit B - Homeland Confidentiality Order, #5 Exhibit C - Middlesex Protective Order, #6 Exhibit D- In re Ethicon Protective Order, #7 Exhibit E - In re Viagra Protective Order, #8 Exhibit F - Eichelberger Protective Order)(aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 98 MOTION for Extension of Time to File Answer with consent by Eli Lilly & Co. Motions referred to Thomas P LeBlanc. Motion Ripe Deadline set for 1/29/2024. (Attachments: #1 Proposed order)(aty,Robertson, Peyton) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 97
ORDER granting #88 Motion for Extension of Time to Answer re #88 Consent MOTION for Extension of Time to File Answer with consent , #1 Complaint. IT IS ORDERED that the Novo Nordisk Defendants be given until 30 days after a decision by the Judicial Panel on Multidistrict Litigation in In Re: Glucagon-like Peptide-1 Receptor Antagonists (GLP-1RAs) Litigation, MDL No. 3094, to file an answer in this matter. Signed by Judge James D Cain, Jr on 1/29/2024. (crt,Bunting, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 96 CORRECTIVE DOCUMENT entitled Corrected signature pages to proposed Protective Order filed by Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc . (aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 95
ELECTRONIC ORDER granting #93 Motion for Extension. Defendants shall submit briefing in support of their position by 01/29/2024 at 5:00 pm as to any remaining dispute regarding the language in the #92 Proposed Protective Order. Signed by Judge James D Cain, Jr on 1/29/2024. (crt,Higgins, M) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 94
ELECTRONIC ORDER REFERRING MOTION: #88 Consent MOTION for Extension of Time to File Answer with consent filed by Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc, Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk Inc, #92 Joint Motion for Protective Order filed by Novo Nordisk A/S, Jaclyn Bjorklund, Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Eli Lilly & Co, Novo Nordisk U S Holdings Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk Research Center Seattle Inc, Novo Nordisk North America Operations A/S, #93 Unopposed MOTION for Extension of Time for Protective Order Briefing with consent filed by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc: Motions referred to Judge Cain. Signed by Judge James D Cain, Jr on 1/29/2024. (crt,Higgins, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Motions Transferred regarding #92 Joint Motion for Protective Order. Motions referred to Judge James D Cain, Jr. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 93 Unopposed MOTION for Extension of Time for Protective Order Briefing with consent by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Thomas P LeBlanc. Motion Ripe Deadline set for 1/26/2024. (Attachments: #1 Proposed order)(aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Motions Transferred regarding #92 Joint Motion for Protective Order., Set/Reset Deadlines as to #92 Joint Motion for Protective Order.(Motion Ripe Deadline set for 1/25/2024.) Motions referred to Magistrate Judge Thomas P LeBlanc. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 92 Joint Motion for Protective Order by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc, Novo Nordisk North America Operations A/S, Novo Nordisk A/S, Eli Lily & Co, Jaclyn Bjorklund. (aty,Surprenant, Diana) Modified on 1/26/2024 to add filers and capture motion event. (Crick, S). Modified on 1/29/2024 to indicate #96 Corrected signature page submitted.(Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 91 NOTICE by Jaclyn Bjorklund PLAINTIFFS MEMORANDUM IN OPPOSITION TO DEFENDANTS PROPOSED RESTRICTIONS ON EMPLOYMENT OF PLAINTIFFS EXPERTS (aty,Autry, Joshua) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 90 MINUTES for proceedings held before Judge James D Cain, Jr: STATUS CONFERENCE held on 1/22/2024. (crt,Stewart, T) Modified to correct date filed and held on 1/23/2024 (Stewart, T). [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 89
ELECTRONIC ORDER: A District Judge Status Conference is set for 1/22/2024 at 01:30 PM by phone before Judge Cain. Counsel shall use the chambers conference line at (877) 873-8018, Access Code: 4800394. Signed by Judge James D Cain, Jr on 1/19/2024. (crt,Higgins, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 88 Consent MOTION for Extension of Time to File Answer with consent by Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Thomas P LeBlanc. Motion Ripe Deadline set for 1/18/2024. (Attachments: #1 Proposed order)(aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 87
ORDER granting #83 Motion for Extension. Deadline for filing joint proposed protective order, or to the extent provisions are disputed, submissions supporting the Parties respective positions is 1/25/2024. IT IS FURTHER ORDERED that the Parties shall have until February 15, 2024 to submit either a joint Order addressing preservation and production of electronically stored information (ESI Protocol) or, to the extent provisions are disputed, submissions supporting the Parties respective positions. Signed by Judge James D Cain, Jr on 1/18/2024. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 86
JUDGMENT in accordance with the #85 Memorandum Ruling, the court hereby ORDERS, ADJUDGES, and DECREES that the Motion to Dismiss for Lack of Personal Jurisdiction #73 be DENIED and the Motion to Dismiss Plaintiffs Express Warranty Claim Pursuant to Rule 12(b)(6) be GRANTED. Accordingly, the express warranty claim asserted against Novo Nordisk A/S and Novo Nordisk North America Operations A/S are hereby DISMISSED WITH PREJUDICE while the failure to warn claims against those defendants and all others in this litigation remain pending. Signed by Judge James D Cain, Jr on 1/18/2024. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 85 MEMORANDUM RULING re #73 MOTION to Dismiss for Lack of Jurisdiction or in the Alternative to Dismiss Plaintiff's Express Warranty Claim Pursuant to Rule 12(b)(6) MOTION to Dismiss For Failure to State a Claim filed by Novo Nordisk A/S, Novo Nordisk North America Operations A/S. Signed by Judge James D Cain, Jr on 1/18/2024. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.] |
| Set Deadlines: The Parties shall have until February 15, 2024 to submiteither a joint Order addressing preservation and production of electronically stored information (ESI Protocol) or, to the extent provisions are disputed, submissions supporting the Parties respective positions. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 84
JUDGMENT: On December 11, 2023, the court issued a Memorandum Ruling and Judgment dismissing the express warranty claim brought by plaintiff against Eli Lilly & Company, without prejudice to plaintiffs right to amend and attempt to cure the deficiencies within 30 days. [Docs 69, 70] That deadline has passed and plaintiff has not filed an amended complaint. Accordingly, IT IS ORDERED, ADJUDGED, and DECREED that plaintiffs express warranty claim against defendant Eli Lilly & Company be DISMISSED WITH PREJUDICE. Signed by Judge James D Cain, Jr on 1/17/2024. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 83 Joint MOTION for Extension of Joint Proposed Protective Order Deadline and Joint Preservation Order Deadline by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc, Eli Lilly & Co, Jaclyn Bjorklund. Motions referred to Thomas P LeBlanc. Motion Ripe Deadline set for 1/17/2024. (Attachments: #1 Proposed order)(aty,Surprenant, Diana) Modified on 1/17/2024 to add filers. (Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 82 REPLY to Response to Motion re #73 MOTION to Dismiss for Lack of Jurisdiction or in the Alternative to Dismiss Plaintiff's Express Warranty Claim Pursuant to Rule 12(b)(6) MOTION to Dismiss For Failure to State a Claim filed by Novo Nordisk A/S, Novo Nordisk North America Operations A/S. (aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 81 ELECTRONIC MINUTE ENTRY issued by the Clerk. Case reassigned to Magistrate Judge Thomas P LeBlanc. Magistrate Judge Kathleen Kay no longer assigned to case. All future filings should bear the name of the new judge assignment. Approved by Judge Terry A Doughty on 1/10/2024. (crt,Kiper, C) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 80
JUDGMENT: On December 8, 2023, the court issued a Memorandum Ruling and Judgment dismissing the express warranty claim brought by plaintiff against Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, and Novo Nordisk U S Holdings Inc., without prejudice to plaintiffs right to amend and attempt to cure the deficiencies within 30 days. [66, 67]. That deadline has passed and plaintiff has not filed an amended complaint. Accordingly, IT IS ORDERED, ADJUDGED, and DECREED that plaintiffs express warranty claim against the above-named entities be DISMISSED WITH PREJUDICE. Signed by Judge James D Cain, Jr on 1/9/2024. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 79 MEMORANDUM in Opposition re #73 MOTION to Dismiss for Lack of Jurisdiction or in the Alternative to Dismiss Plaintiff's Express Warranty Claim Pursuant to Rule 12(b)(6) MOTION to Dismiss For Failure to State a Claim filed by Jaclyn Bjorklund. (Attachments: #1 Exhibit Exhibit List, #2 Exhibit 1- Plaintiffs Declaration, #3 Exhibit 2- Novo Nordisk A/S Company Profile, Bloomberg, #4 Exhibit 3- Novo Nordisk A/S, 2022 Annual Report, #5 Exhibit 4- Novo List of Product Patents, #6 Exhibit 5- Ozempic Patents, #7 Exhibit 6- Trademark, #8 Exhibit 7- Ozempic Label, #9 Exhibit 8- How Wegovy Is Made, #10 Exhibit 9- Dunleavy article, #11 Exhibit 10- FDA correspondence, #12 Exhibit 11- FDA review, #13 Exhibit 12- Cities Where Ozempic Prescriptions Have Risen the Most, #14 Exhibit 13- Louisiana Medicaid Ozempic Reimbursements, #15 Exhibit 14- Novo Trials, #16 Exhibit 15- Spreadsheet of Novo Trials, #17 Exhibit 16- Pennington Biomedical weight loss study, #18 Exhibit 17- Pennington Biomedical semaglutide study, #19 Exhibit 18- Novo semaglutide trial, #20 Exhibit 19- Mapquest, #21 Exhibit 20- La SOS, #22 Exhibit 21- Signal Hire, #23 Exhibit 22- Salary.com, #24 Exhibit 23- LinkedIn, #25 Exhibit 24- Lobbyists, #26 Exhibit 25- Open Corporates, #27 Exhibit 26- Novo NA Op Annual Report, #28 Exhibit 27- Novo US website, #29 Exhibit 28- Novo US Who We Are, #30 Exhibit 29- Exec Management, #31 Exhibit 30- Exec Team, #32 Exhibit 31- Langa, #33 Exhibit 32- Knudsen)(aty,Autry, Joshua) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 78
ELECTRONIC ORDER: The court hereby adopts the scheduling order deadlines set forth in the parties' #77 Joint Proposed Pretrial Order. Additionally, a Pretrial Conference is set for 1/13/2026 at 01:30 PM in chambers before Judge Cain. Pretrial statements are due by 1/6/2026. The parties are given until 1/17/2024 to submit their joint proposed preservation order. Signed by Judge James D Cain, Jr on 12/21/2023. (crt,Higgins, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 77 JOINT PROPOSED PRETRIAL ORDER by Eli Lilly & Co, Novo Nordisk U S Holdings Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk Research Center Seattle Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk North America Operations A/S, Novo Nordisk Inc, Novo Nordisk A/S, Jaclyn Bjorklund . (Attachments: #1 Exhibit Ex. A - Joint Proposed Scheduling Order, #2 Exhibit Ex. B - Plaintiff Proposed Preservation Order, #3 Exhibit Ex. C - Defendants Proposed Preservation Order)(aty,Ieyoub, Christopher) Modified on 12/20/2023 to add filers. (Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 76 NOTICE of Motion Setting without oral argument regarding: #73 MOTION to Dismiss for Lack of Jurisdiction or in the Alternative to Dismiss Plaintiff's Express Warranty Claim Pursuant to Rule 12(b)(6) MOTION to Dismiss For Failure to State a Claim. Motions referred to Judge James D Cain, Jr. Motion day set for 1/31/2024 before Judge James D Cain Jr. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 75 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 74 CORPORATE DISCLOSURE STATEMENT by Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc identifying Corporate Parent Novo Nordisk A/S for Novo Nordisk North America Operations A/S, Novo Nordisk U S Holdings Inc; Corporate Parent Novo Nordisk US Research Investment Holdings Inc for Novo Nordisk Research Center Seattle Inc; Corporate Parent Novo Nordisk US Holdings Inc. for Novo Nordisk U S Commercial Holdings Inc; Corporate Parent Novo Nordisk Manufacturing Holdings Inc for Novo Nordisk Pharmaceutical Industries L P; Corporate Parent Novo Nordisk U S Commercial Holdings Inc. for Novo Nordisk Inc. (aty,Surprenant, Diana) Modified on 12/19/2023 to modify corporate parents and docket text. (Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 73 MOTION to Dismiss for Lack of Jurisdiction or in the Alternative to Dismiss Plaintiff's Express Warranty Claim Pursuant to Rule 12(b)(6) by Novo Nordisk A/S, Novo Nordisk North America Operations A/S. (Attachments: #1 Memorandum / Brief)(Attorney Diana Cole Surprenant added to party Novo Nordisk A/S(pty:dft), Novo Nordisk North America Operations A/S(pty:dft))(aty,Surprenant, Diana). Added MOTION to Dismiss For Failure to State a Claim on 12/19/2023 (Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 72
ORDER denying #71 Motion to Stay. Signed by Judge James D Cain, Jr on 12/18/2023. (crt,Jones, P) [Transferred from Louisiana Western on 2/5/2024.]
|
| Motions Transferred regarding #71 MOTION to Stay . Motions referred to Judge James D Cain, Jr. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 71 MOTION to Stay by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 12/15/2023. (Attachments: #1 Memorandum / Brief, #2 Exhibit, #3 Proposed order)(aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 70
JUDGMENT in accordance with the #69 Memorandum Ruling, the court hereby ORDERS, ADJUDGES, and DECREES that the Motion to Dismiss [doc. 49] be GRANTED as to the express warranty claim and DENIED in all other respects. Accordingly, plaintiffs breach of express warranty claim against defendant Eli Lilly & Co. is hereby DISMISSED, without prejudice to her right to amend the complaint within thirty days and cure the deficiencies noted in the courts ruling. If plaintiff fails to file an amended complaint within that time period, or if the amendment does not cure those deficiencies, the breach of express warranty claim will be dismissed with prejudice. Signed by Judge James D Cain, Jr on 12/11/2023. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 69 MEMORANDUM RULING re #49 Motion to Dismiss for Failure to State a Claim filed by Eli Lilly & Co. Signed by Judge James D Cain, Jr on 12/11/2023. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 68 REPLY to Response to Motion re #49 Motion to Dismiss for Failure to State a Claim filed by Eli Lilly & Co. (aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 67 JUDGMENT #54 Motion to Dismiss for Failure to State a Claim be GRANTED as to the express warranty claim and DENIED in all other respects. Accordingly, plaintiffs breach of express warranty claim against the Novo Nordisk defendants is hereby DISMISSED, without prejudice to her right to amend the complaint within thirty days and cure the deficiencies noted in the courts ruling. Signed by Judge James D Cain, Jr on 12/8/2023. (crt,Jones, P) Modified on 12/11/2023 to correct Judge (Jones, P). [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 66 MEMORANDUM RULING that the #54 MOTION to Dismiss will be GRANTED as to the express warranty claim and DENIED in all other respects. Signed by Judge James D Cain, Jr on 12/8/2023. (crt,Jones, P) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 65 COPY of Motion for Transfer of Actions filed in the United States Judicial Panel on Multidistrict Litigation. (Attachments: #1 Memorandum / Brief, #2 Schedule of Actions, #3 Reason for Oral Argument, #4 Exhibit List, #5 Proof of Service) (crt,Kiper, C) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 64 REPLY to Response to Motion re #54 MOTION to Dismiss For Failure to State a Claim filed by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 63
ELECTRONIC ORDER granting #62 Motion for Leave to File. The clerk is directed to docket the proposed reply brief. Signed by Judge James D Cain, Jr on 12/4/2023. (crt,Higgins, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Motions Transferred regarding #62 MOTION for Leave to File Reply in Support of Motion to Dismiss Plaintiff's First Amended Complaint Pursuant to Rule 12(b)(6) with consent sought but not yet obtained . Motions referred to Judge James D Cain, Jr. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 62 MOTION for Leave to File Reply re #54 MOTION to Dismiss For Failure to State a Claim with consent sought but not yet obtained by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 12/1/2023. (Attachments: #1 Proposed order, #2 Proposed pleading Reply in Support of Motion to Dismiss)(aty,Surprenant, Diana) Modified on 12/4/2023 to create docket entry relationship. (Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 61 MEMORANDUM in Opposition re #54 MOTION to Dismiss For Failure to State a Claim filed by Jaclyn Bjorklund. (aty,Autry, Joshua) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 60 MEMORANDUM in Opposition re #49 Motion to Dismiss for Failure to State a Claim filed by Jaclyn Bjorklund. (aty,Autry, Joshua) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 59
ORDER - The Jury Trial is set for 2/13/2026 09:00 AM in Lake Charles, Courtroom 4 before Judge James D Cain Jr. Signed by Judge James D Cain, Jr on 11/7/2023. (crt,Bunting, M) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 58
ORDER - Parties are to submit a joint proposed scheduling order/discovery plan and a proposed order for the preservation of electronically stored information to the court by 12/19/2023. Signed by Judge James D Cain, Jr on 11/7/2023. (crt,Bunting, M)[Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 57
ORDER - re #49 Motion to Dismiss for Failure to State a Claim filed by Eli Lilly & Co, Set Deadlines/Hearing as to #49 Motion to Dismiss for Failure to State a Claim: Eli Lilly & Co's Replies due by 12/8/2023. Signed by Judge James D Cain, Jr on 11/7/2023. (crt,Bunting, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 56 MINUTES for proceedings held before Judge James D Cain, Jr: SCHEDULING CONFERENCE held on 11/7/2023 pursuant to Federal Rule of Civil Procedure 16. The court and counsel discussed the pending motions to dismiss as well as scheduling issues due to the anticipated complexity of the case. Separate orders will be docketed setting a jury trial and deadlines. (crt,Stewart, T) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 55 NOTICE of Motion Setting without oral argument regarding: #54 MOTION to Dismiss For Failure to State a Claim. Motions referred to Judge James D Cain, Jr. Motion day set for 12/27/2023 before Judge James D Cain Jr. (crt,Bunting, M) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 54 MOTION to Dismiss For Failure to State a Claim by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (Attachments: #1 Memorandum / Brief, #2 Affidavit, #3 Exhibit 2017 Ozempic Label, #4 Exhibit 2020 Ozempic Label, #5 Exhibit Center for Drug Evaluation and Research Part 1, #6 Exhibit Center for Drug Evaluation and Research Part 2, #7 Exhibit Center for Drug Evaluation and Research Part 3, #8 Exhibit 2022 Ozempic Label)(aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 53
ELECTRONIC ORDER CORRECTION TO DOCUMENT #38. The correct call in number is 1-877-873-8018. Signed by Judge James D Cain, Jr on 11/2/2023. (crt,Petrofes, T) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 52 RULE 26(f) Report by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (aty,Surprenant, Diana) Modified on 11/1/2023 to modify docket text. (Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 51
ORDER granting #48 Motion to Appear Pro Hac Vice for appearance of James F Hurst for Eli Lilly & Co. Signed by Magistrate Judge Kathleen Kay on 10/27/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 50 NOTICE of Motion Setting without oral argument regarding: #49 Motion to Dismiss for Failure to State a Claim. Motions referred to Judge James D Cain, Jr. Motion day set for 11/29/2023 before Judge James D Cain Jr. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 49 MOTION to Dismiss Plaintiff's First Amended Complaint for Failure to State a Claim by Eli Lilly & Co. (Attachments: #1 Memorandum / Brief, #2 Proposed order, #3 Affidavit Declaration of Christopher Ieyoub, #4 Exhibit 1, #5 Exhibit 2, #6 Exhibit 3, #7 Exhibit 4, #8 Exhibit 5)(aty,Ieyoub, Christopher) Modified on 10/27/2023 to modify motion event. (Crick, S). [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 48 MOTION for James F. Hurst to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5739386) by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/26/2023. (Attachments: #1 Proposed order, #2 Certificate of good standing)(aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 47
ORDER granting #43 Motion to Appear Pro Hac Vice for appearance of Renee D Smith for Eli Lilly & Co. Signed by Magistrate Judge Kathleen Kay on 10/10/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 46
ORDER granting #41 Motion to Appear Pro Hac Vice for appearance of Diana M Watral for Eli Lilly & Co. Signed by Magistrate Judge Kathleen Kay on 10/10/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 45
ORDER granting #42 Motion to Appear Pro Hac Vice for appearance of Mark W Premo-Hopkins for Eli Lilly & Co. Signed by Magistrate Judge Kathleen Kay on 10/10/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 44
ORDER granting #39 Motion to Enroll as Counsel. Added as counsel V Ed McGuire, III, Peyton Robertson for Eli Lilly & Co. Signed by Magistrate Judge Kathleen Kay on 10/9/2023. (crt,Miletello, A) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 43 MOTION for Renee D. Smith to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5718112) by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/9/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 42 MOTION for Mark W. Premo-Hopkins to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5718108) by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/9/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 41 MOTION for Diana M. Watral to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5718106) by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/9/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 40
ORDER granting #29 Motion to Appear Pro Hac Vice for appearance of Paul J Pennock for Jaclyn Bjorklund. Signed by Magistrate Judge Kathleen Kay on 10/6/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 39 MOTION for V. Ed McGuire, III and Peyton N. Robertson to Enroll as Counsel by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/4/2023. (Attachments: #1 Proposed order)(aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 38
ELECTRONIC ORDER, A Rule 16 District Judge Telephone Conference is set for 11/7/2023 at 10:30 AM before Judge James D Cain Jr. The parties are to call in at 1-877-873-8108, Access Code 4800394.. Signed by Judge James D Cain, Jr on 10/3/2023. (crt,Petrofes, T) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 37
ELECTRONIC ORDER granting #28 Motion for Extension of Time to Answer re #28 MOTION for Extension of Time to File Answer with opposition . Eli Lilly & Co answer due 10/26/2023. Signed by Judge James D Cain, Jr on 10/3/2023. (crt,Petrofes, T) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 36
ORDER granting #22 Motion to Appear Pro Hac Vice for appearance of Loren H Brown for Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Signed by Magistrate Judge Kathleen Kay on 10/3/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 35
ORDER granting #21 Motion to Appear Pro Hac Vice for appearance of Jonathan M Sedgh for Jaclyn Bjorklund. Signed by Magistrate Judge Kathleen Kay on 10/3/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 34
ORDER granting #20 Motion to Appear Pro Hac Vice for appearance of T Michael Morgan for Jaclyn Bjorklund. Signed by Magistrate Judge Kathleen Kay on 10/3/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 33
ORDER granting #19 Motion to Appear Pro Hac Vice for appearance of Josh Autry for Jaclyn Bjorklund. Signed by Magistrate Judge Kathleen Kay on 10/3/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.]
|
|
Filing 32
ELECTRONIC ORDER REFERRING MOTION: #28 MOTION for Extension of Time to File Answer with opposition filed by Eli Lilly & Co. Motions referred to Judge James D Cain, Jr. Signed by Judge James D Cain, Jr on 10/3/2023. (crt,Higgins, M) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 31 MEMORANDUM in Opposition re #28 MOTION for Extension of Time to File Answer with opposition filed by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 30
ELECTRONIC ORDER granting #14 Motion for Extension of Time to Answer #1 Complaint. Novo Nordisk Inc., Novo Nordisk Pharmaceutical Industries, LP, Novo Nordisk Research Center Seattle, Inc., Novo Nordisk U S Commercial Holdings, Inc., and Novo Nordisk U S Holdings, Inc., answers due 11/3/2023. Defendants' request that "that an extension be granted of any related briefing deadlines such that Plaintiffs opposition to any responsive motion is due November 30, 2023, and Lillys reply brief is due December 11, 2023" is denied. Deadlines for responses to any other filings will be fixed at time of filing. Signed by Magistrate Judge Kathleen Kay on 10/3/2023. (jud,Kay, Kathleen) [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 29 MOTION for Paul J. Pennock to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5711378) by Jaclyn Bjorklund. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/2/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 28 MOTION for Extension of Time to File Answer with opposition by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 10/2/2023. (Attachments: #1 Proposed order)(aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 27 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 26 CORPORATE DISCLOSURE STATEMENT by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc identifying Corporate Parent Novo Nordisk A S for Novo Nordisk U S Holdings Inc; Corporate Parent Novo Nordisk U S Research Investment Holdings Inc for Novo Nordisk Research Center Seattle Inc; Corporate Parent Novo Nordisk U S Holdings Inc for Novo Nordisk U S Commercial Holdings Inc; Corporate Parent Novo Nordisk U S Manufacturing Holdings Inc for Novo Nordisk Pharmaceutical Industries L P; Corporate Parent Novo Nordisk U S Commercial Holdings Inc for Novo Nordisk Inc. (aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 25 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Eli Lilly & Co. (aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 24 CORPORATE DISCLOSURE STATEMENT by Eli Lilly & Co. (aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
|
Filing 23
ELECTRONIC ORDER granting #13 Motion for Extension of Time to Answer #1 Complaint and #5 Amended Complaint. Eli Lilly & Co answer due 10/16/2023. Defendant's request that "that an extension be granted of any related briefing deadlines such that Plaintiffs opposition to any responsive motion is due November 8, 2023, and Lillys reply brief is due November 17, 2023" is denied. Deadlines for responses to any other filings will be fixed at time of filing. Signed by Magistrate Judge Kathleen Kay on 9/26/2023. (jud,Kay, Kathleen) Modified on 9/26/2023 to edit text (Jones, P). [Transferred from Louisiana Western on 2/5/2024.]
|
| Filing 22 MOTION for Loren H. Brown to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5699910) by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/21/2023. (Attachments: #1 Certificate of good standing 1 Certificate of Good Standing for Loren Brown, #2 Proposed order)(aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 21 MOTION for Jonathan M. Sedgh to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5699551) by Jaclyn Bjorklund. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/21/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 20 MOTION for T. Michael Morgan to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5696452) by All Plaintiffs. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/19/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 19 MOTION for Josh Autry to Appear Pro Hac Vice (Admission fee: $105, receipt number ALAWDC-5695931) by Jaclyn Bjorklund. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/19/2023. (Attachments: #1 Certificate of good standing, #2 Proposed order)(aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 18 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #14 Motion for Extension of Time to File Answer sent to Diana Cole Surprenant on behalf of Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Diversity Jurisdiction Disclosure Statement due by 9/28/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 17 NOTICE of Corporate Disclosure Statement Requirement re: #14 Motion for Extension of Time to File Answer sent to Diana Cole Surprenant on behalf of Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Corporate Disclosure Statement due by 9/28/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 16 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #13 Motion for Extension of Time to File Answer sent to Christopher P Ieyoub on behalf of Eli Lilly & Co. Diversity Jurisdiction Disclosure Statement due by 9/28/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 15 NOTICE of Corporate Disclosure Statement Requirement re: #13 Motion for Extension of Time to File Answer sent to Christopher P Ieyoub on behalf of Eli Lilly & Co. Corporate Disclosure Statement due by 9/28/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 14 Consent MOTION for Extension of Time to File Answer re #5 Amended Complaint, with consent by Novo Nordisk Inc, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/14/2023. (Attachments: #1 Proposed order)(Attorney Diana Cole Surprenant added to party Novo Nordisk Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk Pharmaceutical Industries L P(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk Research Center Seattle Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk U S Commercial Holdings Inc(pty:dft), Attorney Diana Cole Surprenant added to party Novo Nordisk U S Holdings Inc(pty:dft))(aty,Surprenant, Diana) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 13 MOTION for Extension of Time to File Answer re #1 Complaint,, #5 Amended Complaint, with consent by Eli Lilly & Co. Motions referred to Kathleen Kay. Motion Ripe Deadline set for 9/13/2023. (Attachments: #1 Proposed order)(Attorney Christopher P Ieyoub added to party Eli Lilly & Co(pty:dft))(aty,Ieyoub, Christopher) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 12 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk US Holdings, Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 11 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk US Commercial Holdings, Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 10 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk Research Center Seattle, Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 9 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk Pharmaceutical Industries, LP on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 8 AFFIDAVIT of Service for Summons with First Amended Complaint served on Novo Nordisk Inc. on 8/28/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 7 AFFIDAVIT of Service for Summons with First Amended Complaint served on Eli Lilly & Co. on 8/25/2023, filed by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| SUMMONS Returned Executed by Jaclyn Bjorklund. Eli Lilly & Co served on 8/25/2023, answer due 9/15/2023; Novo Nordisk Inc served on 8/28/2023, answer due 9/18/2023; Novo Nordisk Pharmaceutical Industries L P served on 8/28/2023, answer due 9/18/2023; Novo Nordisk Research Center Seattle Inc served on 8/28/2023, answer due 9/18/2023; Novo Nordisk U S Commercial Holdings Inc served on 8/28/2023, answer due 9/18/2023; Novo Nordisk U S Holdings Inc served on 8/28/2023, answer due 9/18/2023. ADMINISTRATIVE ENTRY as documents electronically filed in error as #7 , #8 , #9 , #10 , #11 & #12 Affidavits of Service. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 6 SUMMONS ISSUED as to Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 5 AMENDED COMPLAINT against Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc with Jury Demand filed by Jaclyn Bjorklund.(aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 4 DIVERSITY JURISDICTION DISCLOSURE STATEMENT by Jaclyn Bjorklund. (aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 3 NOTICE of Diversity Jurisdiction Disclosure Statement Requirement re: #1 Complaint sent to Rene Fernandez Rocha on behalf of Jaclyn Bjorklund. Diversity Jurisdiction Disclosure Statement due by 8/17/2023. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 2 SUMMONS ISSUED as to Eli Lilly & Co, Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries L P, Novo Nordisk Research Center Seattle Inc, Novo Nordisk U S Commercial Holdings Inc, Novo Nordisk U S Holdings Inc. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
| Filing 1 COMPLAINT against Eli Lilly and Company, Novo Nordisk A/S, Novo Nordisk Inc., Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP, Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings Inc., Novo Nordisk US Holdings Inc. with Jury Demand (Filing fee $402, receipt number ALAWDC-5641648) filed by Jaclyn Bjorklund. (Attachments: #1 Civil cover sheet)(Attorney Rene Fernandez Rocha added to party Jaclyn Bjorklund(pty:pla))(aty,Rocha, Rene) [Transferred from Louisiana Western on 2/5/2024.] |
| CASE Assigned to Judge James D Cain, Jr and Magistrate Judge Kathleen Kay. (crt,Crick, S) [Transferred from Louisiana Western on 2/5/2024.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Pennsylvania Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
